This is the logical conclusion of allowing statistics and records determine how outraged we should be about PEDs:
South Korean baseball officials could introduce drastic
anti-doping protocols next year with a plan to target specific players
for drug tests.
The Korean Baseball Organisation (KBO) said players who showed marked
statistical improvement would be targeted in a clampdown on drug
cheats, South Korea’s Yonhap news agency reported on Wednesday . . . League officials said they would begin examining the new testing
procedures at the end of the season with players exceeding their career
averages set to be selected for testing.
We could call it the Norm Cash or the Zolio Versalles Rule.
For what it’s worth, I’m struck by the notion that the vast majority of PED users mentioned in the Mitchell Report and those caught by subsequent testing protocols kind of, you know, sucked. So I can’t see that such a testing procedure ever would have worked all that well here.
(link via BTF)
Extension season continues. The Athletic’s Ken Rosenthal reports that the Cardinals and first baseman Paul Goldschmidt are close to an agreement on a five-year extension. The value is believed to be around $130 million, according to Derrick Goold of the St. Louis Post-Dispatch. Goldschmidt was set to become a free agent after the season.
The Cardinals acquired Goldschmidt, 31, from the Diamondbacks in December in exchange for Luke Weaver, Carson Kelly, Andy Young, and a 2019 competitive balance round B pick. The slugger is a six-time All-Star, a three-time Gold Glove Award winner, and a four-time Silver Slugger Award winner. Goldschmidt owns a career .297/.398/.532 triple-slash line along with 209 home runs, 710 RBI, 709 runs scored, and 124 stolen bases. He is also well-regarded for his defense at first base. As a result, he has accumulated 40.3 Wins Above Replacement over eight seasons, according to Baseball Reference.
With Goldschmidt in place, the Cardinals are set at first base for the foreseeable future. Though Goldschmidt got off to a slow start last season, carrying an OPS barely above .700 into June, he recovered and finished with a .922 OPS. That two-month blip aside, there’s no reason to think Goldschmidt’s production is about to fall off anytime soon.